Using checkpoint inhibitors at earlier stages of bladder cancer – the next step in immunotherapy?
Trial of durvalumab for bladder cancer
Building a clinical research platform to capture and leverage data from cancer care in Germany
Orphan drugs and other treatment options for Merkel cell carcinoma
Immunotherapy: changing the landscape of cancer treatment